Miso Kim
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 15
- CAR-T cell therapy research 7
- Colorectal Cancer Treatments and Studies 5
-
- Lung Cancer Treatments and Mutations 22
- Co-authors
- Bhumsuk Keam (61 shared papers)Dae Seog Heo (45 shared papers)Tae Min Kim (46 shared papers)Dong‐Wan Kim (39 shared papers)Yoon Kyung Jeon (17 shared papers)Chan-Young Ock (10 shared papers)Jong Seok Lee (15 shared papers)Yu Jung Kim (14 shared papers)
- Journals
- Cancer Research and Treatment (12 papers)Journal of Clinical Oncology (10 papers)Journal of Thoracic Oncology (3 papers)ESMO Open (3 papers)Lung Cancer (3 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Miso Kim
83 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 87
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 710
- Cancer Research 208
- Immunology 276
- Otorhinolaryngology 57
Countries citing papers authored by Miso Kim
This map shows the geographic impact of Miso Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miso Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miso Kim more than expected).
Fields of papers citing papers by Miso Kim
This network shows the impact of papers produced by Miso Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miso Kim. The network helps show where Miso Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Miso Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 201 | |
| 2 | 2017 | 137 | |
| 3 | 2016 | 127 | |
| 4 | 2019 | 63 | |
| 5 | 2018 | 62 | |
| 6 | 2018 | 54 | |
| 7 | 2019 | 49 | |
| 8 | 2020 | 46 | |
| 9 | 2019 | 44 | |
| 10 | 2015 | 40 | |
| 11 | 2019 | 39 | |
| 12 | 2015 | 38 | |
| 13 | 2018 | 35 | |
| 14 | 2014 | 33 | |
| 15 | 2014 | 32 | |
| 16 | 2018 | 31 | |
| 17 | 2020 | 31 | |
| 18 | 2021 | 30 | |
| 19 | 2018 | 30 | |
| 20 | The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen. | 2012 | 30 |
About Miso Kim
Miso Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Immunology, having authored 87 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (15 papers), Cancer Genomics and Diagnostics (7 papers), CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (6 papers), Lymphoma Diagnosis and Treatment (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (710 citations), Cancer Research (208 citations), Immunology (276 citations) and Otorhinolaryngology (57 citations). Miso Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Bhumsuk Keam, Dae Seog Heo, Tae Min Kim, Dong‐Wan Kim, Yoon Kyung Jeon, Chan-Young Ock, Jong Seok Lee, Yu Jung Kim, Se Hyun Kim and Doo Hyun Chung. Their work appears in journals such as Cancer Research and Treatment, Journal of Clinical Oncology, Journal of Thoracic Oncology, ESMO Open and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.